Abstract
A wide range of diseases may involve the pleura and pleural space; therefore, pleural effusions are common in the practice of thoracic surgery. Although the management of pleural effusions seems simple, their diagnosis often presents a challenge. Historically, thoracoscopy was the customary approach; today, video-assisted thoracoscopic surgery (VATS) procedures are widely practiced to diagnose and treat pleural diseases. Patients who may have undergone nondiagnostic, noninvasive evaluation in the past should now be offered a VATS procedure to avoid repeated thoracenteses or pleural biopsies.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Pleural Effusion
- Pleural Fluid
- Malignant Pleural Mesothelioma
- Malignant Pleural Effusion
- Pleural Disease
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Introduction
A wide range of diseases may involve the pleura and pleural space; therefore, pleural effusions are common in the practice of thoracic surgery. Although the management of pleural effusions seems simple, their diagnosis often presents a challenge. Historically, thoracoscopy was the customary approach; today, video-assisted thoracoscopic surgery (VATS) procedures are widely practiced to diagnose and treat pleural diseases. Patients who may have undergone nondiagnostic, noninvasive evaluation in the past should now be offered a VATS procedure to avoid repeated thoracenteses or pleural biopsies.
The most common cause of transudative effusion, based on protein and lactate dehydrogenase levels in pleural fluid, is congestive heart failure. Malignancy, infection, and pulmonary emboli are the most common causes of exudative pleural effusion. In specific clinical situations, other biochemical tests (eg, amylase, triglyceride, pH, glucose) may be helpful. Transudative pleural effusions are managed by treating the underlying disease and usually resolve after it has been controlled. Additive intervention (mostly pleurodesis) occasionally may be required if the underlying medical problem is refractory to maximal medical treatment. Some exudative effusions (those caused by nonbacterial infections, gastrointestinal diseases, drugs, malignancy highly responsive to chemotherapy) resolve after specific therapy. However, exudative pleural effusion is the most common indication for diagnostic VATS procedures in malignant and nonmalignant diseases (Antunes et al. 2003).
The goal of the diagnostic approach in exudative effusions is to sample representative tissue probes from the pleura or other structures possibly affected by the underlying disease. The video-assisted approach facilitates inspection of the whole pleural surface as well as the mediastinal face and diaphragmatic recesses; pulmonary wedge resections may be performed concurrently.
The goal of the therapeutic approach, mostly in malignant diseases, is to prevent a repeated manifestation of the pleural effusion. The most common practice today is instillation of sclerosing agents into the pleural cavity to induce an intense chemical pleuritis resulting in pleurodesis, with a reported success rate of 90 % or greater for talc poudrage by VATS. Patients who are not candidates for general anesthesia may be offered instillation of a sclerosant (talc, doxycycline, bleomycin, silver nitrate) via chest tube. In patients with primary tumors of the lung or breast, talc poudrage by VATS seems superior to talc slurry via tube thoracostomy; in other malignancies, the two approaches obtain similar results (Dresler et al. 2005).
Although patients with trapped lung are not candidates for pleurodesis, many experience relief from dyspnea after evacuation of the pleural fluid. Currently, intermittent drainage via an indwelling pleural catheter is the most accepted approach for patients with symptomatic effusion in the presence of a trapped lung. The patient or a caregiver drains the pleural fluid periodically by connecting the tubing to a disposable vacuum container, resulting in a definitive improvement in pulmonary function. However, in up to 58 % of patients, spontaneous pleurodesis may be achieved and the catheter may be removed again (Putnam et al. 2000).
VATS pleurectomy may be considered in select patients with tumors located mainly on the parietal pleural surface or who are not candidates for a simple approach such as talc pleurodesis. Historically, the mortality rate of the thoracotomy approach was up to 18 %; VATS pleurectomy was reported to be associated with a much lower risk. Like pleurodesis, pleurectomy likely will not affect the course of the underlying disease (Waller et al. 1995).
Conclusion
In patients presenting with a pleural effusion, the likely cause should be evaluated initially by a thorough clinical investigation. Unique pleuracentesis and biochemical analysis of the pleural fluid will determine whether the effusion is transudative or exudative. Transudative and benign exudative effusions are managed by treating the underlying disease.
In patients with malignant pleural effusion, the treatment depends on whether the lung can expand after fluid evacuation. If the lung expands fully, the effusion may be managed by sclerosis; talc poudrage by VATS is most effective (Dresler et al. 2005). If the lung is trapped, intermittent drainage via a chronic indwelling pleural catheter is the most accepted approach today. However, the patient’s prognosis and clinical condition also must be considered. For talc pleurodesis, the reported rate of respiratory complications is as high as 14 %, representing the most frequent causes of treatment-related death (2–3 %). As a palliative approach, the treatment of malignant pleural effusion must be safe and effective, with the least amount of invasiveness and the shortest possible hospital stay. VATS requiring general anesthesia and single-lung ventilation is not sustainable in patients presenting with a malignant pleural effusion who are in poor clinical condition and have a limited life expectancy. For these patients, implantation of a chronic indwelling catheter under local anesthesia is a suitable alternative as an outpatient procedure and should cause minimal morbidity or mortality (Putnam et al. 2000).
If there is an intraoperative finding of a partially trapped lung during VATS, as well as limited tumor on the visceral surface, talc pleurodesis also may be combined with a chronic indwelling catheter. An incremental expansion of the entrapped parts of the lung may be achieved in many patients, and the catheter may then be removed (Putnam et al. 2000).
The surgeon must consider each patient’s condition and prognosis when deciding whether to perform a pleurectomy. Certainly, the morbidity and mortality of thoracotomy are not acceptable. Although the VATS approach seems much less invasive, its use in pleurectomy was not widespread until recently. In only a few patients with very little tumor can pleurectomy influence the course of the underlying disease. Actually, pleurectomy is best reserved for patients with breast cancer and malignant pleural mesothelioma; randomized studies comparing VATS pleurodesis to VATS pleurectomy did not exist until now (Waller et al. 1995).
References
Antunes G, Neville E, Duffy J, Ali N (2003) BTS guidelines for the management of malignant pleural effusions. Thorax 58(Suppl 2):ii29–ii38
Dresler CM, Olak J, Herndon JE 2nd, Richards WG, Scalzetti E, Fleishman SB, Kernstine KH, Demmy T, Jablons DM, Kohman L et al (2005) Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 127:909–915
Putnam JB Jr, Walsh GL, Swisher SG, Roth JA, Suell DM, Vaporciyan AA, Smythe WR, Merriman KW, DeFord LL (2000) Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 69:369–375
Waller DA, Morritt GN, Forty J (1995) Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest 107:1454–1456
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schneider, T. (2015). Benign and Malignant Pleural Effusions. In: Dienemann, H., Hoffmann, H., Detterbeck, F. (eds) Chest Surgery. Springer Surgery Atlas Series. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12044-2_36
Download citation
DOI: https://doi.org/10.1007/978-3-642-12044-2_36
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12043-5
Online ISBN: 978-3-642-12044-2
eBook Packages: MedicineMedicine (R0)